North Star Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.7K Buy
385
+136
+55% +$17.9K ﹤0.01% 750
2026
Q1
$34.7K Buy
249
+6
+2% +$840 ﹤0.01% 812
2025
Q4
$29.9K Buy
243
+86
+55% +$10.5K ﹤0.01% 777
2025
Q3
$17.5K Buy
157
+5
+3% +$568 ﹤0.01% 829
2025
Q2
$16.9K Buy
152
+1
+0.7% +$106 ﹤0.01% 813
2025
Q1
$17K Sell
151
-75
-33% -$7.74K ﹤0.01% 782
2024
Q4
$20.9K Sell
226
-169
-43% -$15.2K ﹤0.01% 753
2024
Q3
$33.1K Buy
395
+47
+14% +$3.59K ﹤0.01% 663
2024
Q2
$23.9K Sell
348
-540
-61% -$36K ﹤0.01% 693
2024
Q1
$65K Buy
888
+4
+0.5% +$308 ﹤0.01% 571
2023
Q4
$71.6K Buy
884
+1
+0.1% +$78 0.01% 539
2023
Q3
$66.2K Buy
883
+22
+3% +$1.69K 0.01% 547
2023
Q2
$66.4K Buy
861
+1
+0.1% +$80 0.01% 562
2023
Q1
$71.4K Buy
860
+1
+0.1% +$83 0.01% 565
2022
Q4
$73.7K Buy
859
+193
+29% +$15.3K 0.01% 534
2022
Q3
$41K Buy
666
+2
+0.3% +$126 ﹤0.01% 574
2022
Q2
$41K Buy
664
+1
+0.2% +$62 ﹤0.01% 586
2022
Q1
$39K Sell
663
-711
-52% -$45.4K ﹤0.01% 632
2021
Q4
$100K Sell
1,374
-316
-19% -$21.8K 0.01% 483
2021
Q3
$118K Buy
1,690
+1
+0.1% +$70 0.01% 448
2021
Q2
$116K Buy
1,689
+101
+6% +$6.74K 0.01% 457
2021
Q1
$103K Buy
1,588
+669
+73% +$43.1K 0.01% 446
2020
Q4
$54K Sell
919
-23,247
-96% -$1.4M 0.01% 523
2020
Q3
$1.53M Buy
24,166
+5,846
+32% +$405K 0.18% 130
2020
Q2
$1.41M Buy
18,320
+16,755
+1,071% +$1.28M 0.18% 132
2020
Q1
$117K Sell
1,565
-23,997
-94% -$1.66M 0.02% 378
2019
Q4
$1.66M Buy
25,562
+24,002
+1,539% +$1.56M 0.17% 144
2019
Q3
$99K Buy
+1,560
New +$102K 0.01% 428
2019
Q2
Sell
-2,208
Closed -$144K 597
2019
Q1
$144K Buy
2,208
+9
+0.4% +$598 0.02% 394
2018
Q4
$138K Buy
2,199
+226
+11% +$15.8K 0.02% 374
2018
Q3
$152K Sell
1,973
-58
-3% -$4.38K 0.02% 381
2018
Q2
$144K Buy
2,031
+6
+0.3% +$424 0.02% 395
2018
Q1
$153K Buy
2,025
+939
+86% +$74.6K 0.02% 383
2017
Q4
$78K Sell
1,086
-81
-7% -$6.15K 0.01% 474
2017
Q3
$95K Buy
1,167
+87
+8% +$6.65K 0.01% 438
2017
Q2
$76K Sell
1,080
-177
-14% -$11.8K 0.01% 464
2017
Q1
$85K Buy
1,257
+280
+29% +$19.7K 0.01% 444
2016
Q4
$70K Sell
977
-597
-38% -$44.4K 0.01% 444
2016
Q3
$124K Sell
1,574
-591
-27% -$48K 0.02% 322
2016
Q2
$181K Buy
2,165
+700
+48% +$62.1K 0.03% 292
2016
Q1
$135K Buy
1,465
+54
+4% +$4.87K 0.03% 306
2015
Q4
$143K Hold
1,411
0.03% 312
2015
Q3
$139K Buy
1,411
+895
+173% +$99.4K 0.03% 306
2015
Q2
$60K Hold
516
0.01% 378
2015
Q1
$51K Hold
516
0.01% 379
2014
Q4
$49K Buy
516
+100
+24% +$10.3K 0.01% 379
2014
Q3
$44K Hold
416
0.01% 380
2014
Q2
$34K Hold
416
0.01% 425
2014
Q1
$29K Buy
+416
New +$32.6K 0.01% 429

Other funds holding GILD

North Star Investment Management's GILD Position: Q2 2026 in Review

North Star Investment Management increased its Gilead Sciences (GILD) stake by 55% in Q2 2026, buying an estimated $17.9K and bringing the position to 385 shares worth $48.7K. The position accounts for ﹤0.01% of the portfolio, ranked #750.

North Star Investment Management first reported a position in GILD in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.66M in Q4 2019. 975 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • North Star Investment Management held 385 shares of Gilead Sciences worth $48.7K as of Q2 2026.
  • North Star Investment Management bought 136 Gilead Sciences shares in Q2 2026, an estimated $17.9K.
  • Gilead Sciences made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #750 holding.
  • North Star Investment Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 49 quarters since.
  • North Star Investment Management's Gilead Sciences position peaked at $1.66M in Q4 2019.
  • 975 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.